Cargando…
The RANGER II superficial femoral artery trial: 1-year results of the long lesion cohort
BACKGROUND: The objective of the RANGER II SFA long lesion cohort analysis was to evaluate the safety and effectiveness of the Ranger drug-coated balloon (DCB) in patients with lesion lengths greater than 100 mm. METHODS: Patients from the RANGER II SFA randomized controlled trial and long balloon s...
Autores principales: | Schroë, Herman, Sachar, Ravish, Keirse, Koen, Soga, Yoshimitsu, Brodmann, Marianne, Rao, Vikram, Werner, Martin, Holden, Andrew, Lopez, Louis, Krishnan, Prakash, Diaz-Cartelle, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551318/ https://www.ncbi.nlm.nih.gov/pubmed/35943120 http://dx.doi.org/10.1177/1358863X221097164 |
Ejemplares similares
-
Twisting of the Ranger drug‐coated balloon for treating superficial femoral artery disease
por: Kim, Su Hong, et al.
Publicado: (2022) -
Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016) -
“Low Echoic Area” around stent after bare and drug-coated stenting or stent graft placement for superficial femoral artery disease
por: Soga, Yoshimitsu, et al.
Publicado: (2021) -
The Texas Rangers; a century of frontier defense
por: Webb, Walter Prescott, 1888-1963
Publicado: (1965) -
Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
por: Krishnan, Prakash, et al.
Publicado: (2017)